Chemoinformaics analysis of (r)-2-Butyl-1-propenyl disulphide
| Molecular Weight | 258.496 | nRot | 9 |
| Heavy Atom Molecular Weight | 232.288 | nRig | 2 |
| Exact Molecular Weight | 258.148 | nRing | 0 |
| Solubility: LogS | -6.028 | nHRing | 0 |
| Solubility: LogP | 6.093 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 46.5166 |
| nHD | 0 | BPOL | 28.5434 |
| QED | 0.339 |
| Synth | 3.416 |
| Natural Product Likeliness | 0.525 |
| NR-PPAR-gamma | 0.86 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.015 |
| Pgp-sub | 0.001 |
| HIA | 0.043 |
| CACO-2 | -4.575 |
| MDCK | 0.0000224 |
| BBB | 0.807 |
| PPB | 0.98034 |
| VDSS | 2.398 |
| FU | 0.0117461 |
| CYP1A2-inh | 0.962 |
| CYP1A2-sub | 0.45 |
| CYP2c19-inh | 0.927 |
| CYP2c19-sub | 0.57 |
| CYP2c9-inh | 0.676 |
| CYP2c9-sub | 0.949 |
| CYP2d6-inh | 0.836 |
| CYP2d6-sub | 0.4 |
| CYP3a4-inh | 0.735 |
| CYP3a4-sub | 0.203 |
| CL | 9.555 |
| T12 | 0.313 |
| hERG | 0.006 |
| Ames | 0.017 |
| ROA | 0.048 |
| SkinSen | 0.965 |
| Carcinogencity | 0.033 |
| EI | 0.982 |
| Respiratory | 0.978 |
| NR-Aromatase | 0.288 |
| Antiviral | Yes |
| Prediction | 0.794683 |